期刊文献+

冠状动脉粥样硬化性心脏病合并甲状腺功能异常的治疗 被引量:2

The treatment of coronary artery disease with thyroid dysfunction
下载PDF
导出
摘要 目的 探讨冠状动脉粥样硬化性心脏病 (冠心病 )合并甲状腺功能异常的治疗策略。方法与结果  2 0 0 0年 5月到 2 0 0 3年 5月在我院心血管中心住院治疗的冠心病合并甲状腺功能异常 14例。其中ST段抬高的急性心肌梗死合并甲状腺功能减退 (甲减 ) 2例 ,1例直接经皮冠状动脉腔内成形术 (PTCA +支架 )治疗成功 ,1例广泛前壁心梗 ,尿激酶溶栓未通 ,未行介入治疗 ,死于左心衰。不稳定心绞痛 12例 ,其中合并甲状腺功能亢进 (甲亢 ) 5例 ,经药物治疗 ,4例心绞痛消失 ,1例心绞痛由Ⅳ级变为Ⅱ级 ,择期PTCA +支架置入治疗成功 ;合并甲减 7例 ,药物治疗 ,6例心绞痛消失 ,1例重症甲减心绞痛由Ⅱ级变为Ⅳ级 ,择期冠状动脉搭桥 (CABG)治疗成功。结论 ST段抬高的心肌梗死合并甲状腺功能异常应早期再灌注治疗 ;合并甲状腺功能异常的不稳定心绞痛 ,在药物稳定甲状腺功能基础上 ,行PTCA、CABG或药物治疗。 Objective To investigate the therapeutic principle of coronary artery disease(CAD) with thyroid dysfunction.Methods and Results 14 patients with CAD and thyroid dysfunction admitted to our Heart and Blood Vessel Center from May 2000 to May 2003 underwent different treatments.2 patients with ST segments elevation of acute myocardial infarction(AMI) and hypothyroidism, one of them got well after primary percutaneous transluminal coronary angioplasty (PTCA)+Stent, the other who was extensive anteroseptal infarction died of left heart failure without invasive treatment after ineffective urine kinase thrombolysis. In 12 patients with unstable angina (UA), five had hyperthyroidism. after drug therapy, UA of four patients disappeared after the improvement of thyroid function with medicine,PTCA+Stent succeeded in left patient. 7 patients had hypothyroidism, UA of six patients disappeared after the improvement of thyroid function with medicine, coronary artery bypass graft (CABG) succeeded in left patient. Conclusions Patients with ST segments elevation of AMI and thyroid dysfunction should undergo reperfusion at early phase; patients with UA and thyroid dysfunction should undergo PTCA、CABG or drug therepy.
出处 《海南医学》 CAS 2004年第11期7-8,共2页 Hainan Medical Journal
关键词 治疗 甲状腺功能异常 心绞痛 甲减 冠状动脉粥样硬化性心脏病 CABG PICA 合并 结论 中心 coronary artery disease hypothyroidism hyperthyroidism
  • 相关文献

参考文献7

  • 1林丽香.甲亢的心血管系统表现及其处理[J].中国实用内科杂志,1997,17(12):708-710. 被引量:71
  • 2Sheman SI,Ladenson PW.Percutaneous transhminal coronary angioplasty in hypothyroidism.Am J Med,1991,90:367-370.
  • 3Keating FR,Parkin TW,Selby JB,et al.Treatment of heart disease associated with myxedema.Prog Cardiovasc Dis,1960.3:364-381.
  • 4Aronow WS. The heart and thyroid diseaes.Clinics in Geriatric Medicine,1995,11(2):219-227.
  • 5Perk M,O'Neill BJ.The effect of thyroid hormone therapy on angiographic coronary artery disease progression.Can J Cardiol ,1997,13:273-276.
  • 6Hay ID, Duick DS,Vlietstra RE,et al.Thyroxine therapy in hypothyroid paticnts undorgoing coronary revasculsrization:a retroepective analysis.Ann Intern Med,1981,95(4):456-457.
  • 7Drucker DJ,Burrow GN.Cardiovascular surgery in the hypothyroid psticnt.Arch Interm Med,1985,145:1585-1587.

共引文献70

同被引文献12

  • 1韩书宏.甲亢性心脏病76例临床分析[J].中国医药导报,2006,3(15):24-25. 被引量:4
  • 2孙玉胜,时兢.甲亢性心脏病60例临床分析[J].实用临床医学(江西),2005,6(5):13-15. 被引量:7
  • 3纪文新,王赫男,张远卓,张震环,孙丕东.老年人甲亢性心脏病36例临床分析[J].中国地方病防治,2006,21(4):252-254. 被引量:1
  • 4[1]史轶蘩,主编.协和内分泌和代谢学.北京:科学出版社,2000.674-720.
  • 5[2]ginugawa K,Yonekura K,Pdbeiro RC,et al.Regulation ofthyroid hormone recptor isoforms in physiological and pathologicalcardiac hypertrophy.Cire Res,2001,89:591-598.
  • 6[3]Pantos C,Malliopoulou V,Varonos DD,et al.Thyroid hotmoneand phenotypes of eardioprotection.Basic Res Cardid,2004,99:101-120.
  • 7[4]Venditti P,De Rosa R,Cigliano L,et al.Role of nitric oxidein the functional response to ischemia reperfuslon of heartmitochondria from hyperthyroid rats.Cell Mol Life Sci,2004,61:2244-2252.
  • 8叶任高.内科学[M](第5版)[M].北京:人民卫生出版社,2002.392-402.
  • 9史轶蘩.协和内分泌和代谢学[M].北京:科学出版社,2000,1.1120.
  • 10Kinugawa K,Yonekura K,Ribeiro RC,et al.Regulation of thyroid hormone recptor isoforms in physiological and pathological cardiac hypertrophy[J].Circ Res,2001,89 (7):591~ 598.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部